Skip to main content
Glama

Arcgis Tucson

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare read-only, idempotent, and non-destructive hints, which the description reinforces and expands upon. It discloses internal cascading through multiple endpoints, source-specific behavior (GLEIF/OpenFIGI/RxNorm), graceful degradation when sources are unavailable, handling of ambiguous matches (returns figi_candidates), and explicit reporting of unresolved identifiers. This goes well beyond the annotation hints, providing rich behavioral context.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but every sentence carries useful information. It front-loads the key directive ('Use FIRST...') and examples, then progressively details edge cases. While it could be more structured (e.g., separated paragraphs for company vs drug), it avoids redundancy and waste.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a complex tool with two entity types, multiple data sources, and ambiguity handling, the description is remarkably thorough. It covers input formats, source-specific behavior, graceful degradation, and edge cases. However, it does not explicitly describe the output structure (e.g., exact keys or nested layout), which would be helpful given there is no output schema.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% (both type and value are described), but the description adds substantial meaning beyond it. It explains how the 'type' parameter affects resolution behavior, gives concrete examples for 'value' (ticker format, CIK with leading zeros, drug names), and warns about common pitfalls (e.g., not passing full security-class words). This significantly improves parameter understanding.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a clear verb and resource: 'resolve a user-spoken NAME to the canonical/official identifiers'. It provides concrete example queries and explicitly names the supported entity types (company, drug), and distinguishes itself from manual lookups ('replaces 2-3 manual lookups'). The purpose is unambiguous and separable from sibling tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives a direct directive: 'Use FIRST whenever you have a name but need an ID.' It provides detailed input rules, including what to pass for bonds (issuer name exactly) and drugs (brand/generic name), as well as a warning about not including full noun phrases. However, it does not explicitly contrast with sibling tools like entity_profile or compare_entities, leaving a slight gap in alternative selection.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Arcgis Tucson toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation3/5

While individual tool descriptions are detailed and specific, the set includes overlapping tools like ask_pipeworx and ask_pipeworx_grounded, and several prediction market tools with similar purposes (bet_research, polymarket_edges, polymarket_arbitrage). The broad range of unrelated domains means many tools are distinct, but some pairs are ambiguous.

Naming Consistency2/5

Tool names use snake_case but follow no consistent pattern. Some are verb_noun (ask_pipeworx, query_layer), some noun_verb (ai_visibility_check, entity_profile), and some have inconsistent structure (discover_tools, recent_alerts). The mix of conventions reduces predictability.

Tool Count1/5

33 tools is excessive for a server named 'Arcgis Tucson', as only 3 tools relate to ArcGIS (search_datasets, layer_info, query_layer). The rest span completely unrelated domains (Pipeworx data, Polymarket, memory, npm scanning, etc.), creating a severe mismatch between server name and tool functionality.

Completeness3/5

Considering the actual tool surface (a diverse data retrieval and prediction market analysis set), it is reasonably complete for common lookups (SEC, FDA, economics, news, bets). However, it lacks web search and the ArcGIS tools are minimal. The absence of a cohesive domain makes completeness hard to judge, but for the implied data-retrieval purpose, it's passable.

Resources